RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 14 2024 - 4:05PM
(NASDAQ: RXST) - RxSight, Inc., an ophthalmic
medical device company dedicated to providing high-quality
customized vision to patients following cataract surgery, today
announced that it will report financial results for the fourth
quarter and full year 2023 after the market close on Wednesday,
February 28, 2024. The company’s management will discuss the
results during a conference call beginning at 1:30 p.m. Pacific
Time / 4:30 p.m. Eastern Time.
Participants may register for the call here and listen through a
live and archived webcast of the event available for one year at
https://investors.rxsight.com/. While not required, it is
recommended that participants join ten minutes prior to the event
start time to ensure the necessary audio applications are
downloaded and installed. Instructions are provided (including a
dial-in option).
About RxSight, Inc.RxSight, Inc. is an
ophthalmic medical device company dedicated to providing
high-quality customized vision to patients following cataract
surgery. The RxSight® Light Adjustable Lens system, comprised of
the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery
Device (LDD™) and accessories, is the first and only commercially
available intraocular lens (IOL) technology that can be adjusted
after surgery, enabling doctors to customize and deliver
high-quality vision to patients after cataract surgery. Additional
information about RxSight can be found at www.rxsight.com.
Company Contact:Shelley B. ThunenChief
Financial Officersthunen@rxsight.com
Investor Relations Contact:Oliver MoravcevicVP,
Investor Relationsomoravcevic@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Apr 2024 to May 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From May 2023 to May 2024